These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Operator assistance with process improvement. NIATx helps one agency reduce waiting times from 21 days to 24 hours. Fitzgerald M Behav Healthc; 2006 May; 26(5):20, 22. PubMed ID: 16736914 [No Abstract] [Full Text] [Related]
6. [Drug abuse and health district: value and role of an interface]. Vignat JP Soins Psychiatr; 1995; (177):38-40. PubMed ID: 8711523 [No Abstract] [Full Text] [Related]
8. Enhancing transitions from addiction treatment to primary care. Cucciare MA; Coleman EA; Saitz R; Timko C J Addict Dis; 2014; 33(4):340-53. PubMed ID: 25299380 [TBL] [Abstract][Full Text] [Related]
9. Training in addiction medicine should be standardised and scaled up. Klimas J BMJ; 2015 Jul; 351():h4027. PubMed ID: 26220548 [TBL] [Abstract][Full Text] [Related]
10. Everybody likes same-day service. An opioid treatment program decreases its no-show rate by offering a same-day admissions process. Theriault D; Nolan K Behav Healthc; 2008 Apr; 28(4):52-3. PubMed ID: 18524368 [No Abstract] [Full Text] [Related]
11. Penetration of publicly-funded substance abuse services in North Carolina. Clark S; Menon N N C Med J; 2009; 70(1):82-4. PubMed ID: 19534067 [No Abstract] [Full Text] [Related]
12. Mental illness and substance use: an Australian perspective. Munro I; Edward KL Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908 [TBL] [Abstract][Full Text] [Related]
17. Addiction treatment agencies' use of data: a qualitative assessment. Wisdom JP; Ford Ii JH; Hayes RA; Edmundson E; Hoffman K; McCarty D J Behav Health Serv Res; 2006 Oct; 33(4):394-407. PubMed ID: 17082981 [TBL] [Abstract][Full Text] [Related]
18. School-based substance abuse prevention: a public health perspective. Thomas A; Davies S N C Med J; 2008; 69(6):502-4. PubMed ID: 19256195 [No Abstract] [Full Text] [Related]
19. Access to health and social services for IDU: the impact of a medically supervised injection facility. Small W; Van Borek N; Fairbairn N; Wood E; Kerr T Drug Alcohol Rev; 2009 Jul; 28(4):341-6. PubMed ID: 19594786 [TBL] [Abstract][Full Text] [Related]
20. [Supervised off-label prescribing of topiramate for binge eating disorder within the system CAMTEA]. Guardia D; Rolland B; Deheul S; Danel T; Bordet R; Cottencin O Therapie; 2012; 67(5):480-1. PubMed ID: 23241259 [No Abstract] [Full Text] [Related] [Next] [New Search]